Joseph Francis Hokello
Bioprospecting for HIV-1 latency reversing agent (prostratin) from indigenous medicinal plants for latency reversal in HIV-1 subtypes A and D in Uganda (HIV-1_AD_LRA study)-PHASE-3
Joseph Francis Hokello

Outcomes

Evidence of PROVIRID’s efficacy in HIV-1 subtypes A and D. Contribution to HIV cure research. Capacity building through MSc thesis research. Strengthened partnerships with TASO, UVRI, and DGAL.